{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["AMPK", "TF", "chemotherapeutic enteritis", "ozone", "thrombosis"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32776374", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "08", "Day": "09"}], "ELocationID": ["10.1096/fj.201902717RR"], "Journal": {"ISSN": "1530-6860", "JournalIssue": {"Volume": "34", "Issue": "9", "PubDate": {"Year": "2020", "Month": "Sep"}}, "Title": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology", "ISOAbbreviation": "FASEB J"}, "ArticleTitle": "AMPK activation by ozone therapy inhibits tissue factor-triggered intestinal ischemia and ameliorates chemotherapeutic enteritis.", "Pagination": {"StartPage": "13005", "EndPage": "13021", "MedlinePgn": "13005-13021"}, "Abstract": {"AbstractText": ["Chemotherapeutic enteritis is a major dose-limiting adverse reaction to chemotherapy, with few effective drugs in clinic. Intestinal ischemic injury plays prominent role in chemotherapeutic enteritis clinically. However, mechanism is not clear. In this article, irinotecan (CPT-11) was used to establish chemotherapeutic enteritis mice model. Western blotting, gelatin zymography, immunohistochemistry (IHC), Laser Doppler flowmetry (LDF) were used to detect the pathogenesis of ischemia-hypoxia injury. CPT-11 increased levels of tissue factor (TF) both in the blood and in intestines, and decreased the intestinal blood flow in mice. Interestingly, the elevation of TF in the blood displayed \"double-peak,\" which was consistent with the intestinal mucosal \"double-strike\" injury trend. Intestinal microthrombus and mixed thrombus formation were detectable in chemotherapeutic enteritis. Furthermore, ozone therapy relieved chemotherapeutic enteritis in mice. Ozone inhibited TF expression induced by CPT-11 via activating AMPK/SOCS3, and effectively ameliorated the intestinal mucosal injury in mice. Moreover, ozone autotransfusion therapy effectively attenuated chemotherapeutic enteritis and the blood hypercoagulability in patients. For the first time, we proposed that TF-induced thrombotic intestinal ischemic injury is a core trigger pathological mechanism of chemotherapeutic enteritis, and provided a new treatment strategy, ozone therapy, to suppress TF expression and treat chemotherapeutic enteritis."], "CopyrightInformation": "\u00a9 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Oncology, Jining No.1 People's Hospital, Jining, P.R. China."}], "LastName": "Yu", "ForeName": "Qingqing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Yang", "ForeName": "Xing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Zhang", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Radiation Oncology, Qingdao Central Hospital, Qingdao, P.R. China."}], "LastName": "Zhang", "ForeName": "Xiaotao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Wang", "ForeName": "Chaoyu", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Chen", "ForeName": "Lu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shandong Provincial Qianfoshan Hospital, the First Hospital Affiliated with Shandong First Medical University, Jinan, P.R. China."}], "LastName": "Liu", "ForeName": "Xiaolin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Gu", "ForeName": "Yufeng", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Clinical Research and Translational Medicine, The Affiliated Lianyungang Oriental Hospital of Kangda College of Nanjing Medical University, Lianyungang, China."}], "LastName": "He", "ForeName": "Xueming", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Hu", "ForeName": "Liang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, P.R. China."}, {"Identifier": [], "Affiliation": "Institute of Translational Medicine, Nanjing Medical University, Nanjing, P.R. China."}], "LastName": "Liu", "ForeName": "Wen-Tao", "Initials": "WT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Oncology, Shandong Provincial Qianfoshan Hospital, the First Hospital Affiliated with Shandong First Medical University, Jinan, P.R. China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}], "GrantList": [{"GrantID": "2018CXGC1220", "Agency": "Major Science and Technology Innovation Project of Shandong Province", "Country": "International"}, {"GrantID": "2017NJMUCX004", "Agency": "Major Project of \"Science and Technology Innovation Fund\" of Nanjing Medical University", "Country": "International"}, {"GrantID": "BK20161033", "Agency": "Natural Science Foundation for Young Scientists of Jiangsu province", "Country": "International"}, {"GrantID": "SF2016", "Agency": "Lianyungang 2020 covid-19 emergency science and technology special fund", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "FASEB J", "NlmUniqueID": "8804484", "ISSNLinking": "0892-6638"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7673326042", "NameOfSubstance": "Irinotecan"}, {"RegistryNumber": "9035-58-9", "NameOfSubstance": "Thromboplastin"}, {"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Enteritis"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Irinotecan"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism", "pathology"], "DescriptorName": "Reperfusion Injury"}, {"QualifierName": ["metabolism"], "DescriptorName": "Thromboplastin"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120:1453-1461."}, {"Citation": "Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J, Committee EG. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015;26(Suppl 5):v139-v151."}, {"Citation": "Maroun JA, Anthony LB, Blais N, et al. Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea. Curr Oncol. 2007;14:13-20."}, {"Citation": "Van Sebille YZ, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of mucositis during chemotherapy: From pathophysiology to pragmatic therapeutics. Curr Oncol Rep. 2015;17:50."}, {"Citation": "Paran H, Edelstein E, Klein B, Gutman M. Extensive colonic ischemia following treatment with bevacizumab, fluouracil and CPT-11 in a young patient with advanced adenocarcinoma of the rectum. Isr Med Assoc J. 2007;9:488-489."}, {"Citation": "Elsayed AG, Srivastava R, Pacioles T, Limjoco T, Tirona MT. Ischemic colitis associated with paclitaxel and carboplatin combination. Case Rep Oncol. 2017;10:689-693."}, {"Citation": "Maggo G, Grover SC, Grin A. Capecitabine induced colitis. Pathol Res Pract. 2014;210:606-608."}, {"Citation": "Tashiro M, Yoshikawa I, Kume K, Otsuki M. Ischemic colitis associated with paclitaxel and carboplatin chemotherapy. Am J Gastroenterol. 2003;98:231-232."}, {"Citation": "H\u00fcbner J, Handrup R, Vogel J. Isch\u00e4mische Kolitis im Verlauf der Chemotherapie beim Mammakarzinom. Der Onkologe. 2006;12:565-567."}, {"Citation": "Yokoyama T, Kondo H, Yokota T, et al. Colonoscopy for frank bloody stools associated with cancer chemotherapy. Jpn J Clin Oncol. 1997;27:111-114."}, {"Citation": "Marmur JD, Rossikhina M, Guha A, et al. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993;91:2253."}, {"Citation": "Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097."}, {"Citation": "Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res. 2006;118:555-568."}, {"Citation": "Lechner D, Weltermann A. Pathophysiologie der Chemotherapie-assoziierten Thrombose. Onkologische Welt. 2010;01:129-134."}, {"Citation": "Apetoh L, Ghiringhelli F, Tesniere A, et al. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev. 2007;220:47-59."}, {"Citation": "Paolini A, Pasi F, Facoetti A, et al. Cell death forms and HSP70 expression in U87 cells after ionizing radiation and/or chemotherapy. Anticancer Res. 2011;31:3727-3731."}, {"Citation": "Yu Z, Tong Y, Zhang R, Ding X, Li Q. Saquinavir ameliorates liver warm ischemia-reperfusion-induced lung injury via HMGB-1- and P38/JNK-mediated TLR-4-dependent signaling pathways. Mediators Inflamm. 2017;2017:7083528."}, {"Citation": "Zhe Y, Li Y, Liu D, Su DM, Liu JG, Li HY. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway. Tumour Biol. 2016;37:13951-13959."}, {"Citation": "Yang Y, Hu L, Wang C, et al. p38/TF/HIF-\u03b1 signaling pathway participates in the progression of CIPN in mice. Biomed Res Int. 2019;2019:1-11."}, {"Citation": "Li Y, Zhang H, Kosturakis AK, et al. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun. 2015;49:255-266."}, {"Citation": "Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454-465."}, {"Citation": "Mahony R, Ahmed S, Diskin C, Stevenson NJ. SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci. 2016;73:3323-3336."}, {"Citation": "Bocci V, Borrelli E, Zanardi I, Travagli V. The usefulness of ozone treatment in spinal pain. Drug Des Devel Ther. 2015;9:2677-2685."}, {"Citation": "Lopes de Jesus CC, Dos Santos FC, de Jesus L, Monteiro I, Sant'Ana M, Trevisani VFM. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: a randomized, double-blinded, placebo-controlled study. PLoS One. 2017;12:e0179185."}, {"Citation": "Lu L, Pan C, Chen L, et al. AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in rats. J Mol Cell Biol. 2017;9:132-143."}, {"Citation": "Zhang Y, Tao GJ, Hu L, et al. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord. J Neuroinflammation. 2017;14:211."}, {"Citation": "Xiong AJ, Yong W, Yan QX, et al. Expert consensus on ozonated autohemotherapy. Transl Med J. 2018;7:326-328."}, {"Citation": "Wang L, Liu WZ, Pei LY, Ke YS, Cui J, Li SC. Garidisan: improving the quality of ulcer healing in rats with ulcerative colitis. Evid Based Complement Alternat Med. 2017;2017:8721257."}, {"Citation": "Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-Ethyl-10-[4-(l-piperidino)-l-piperidino]carbonyloxycamptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Can Res. 1987;47:4."}, {"Citation": "Chen L, You Q, Hu L. The antioxidant procyanidin reduces reactive oxygen species signaling in macrophages and ameliorates experimental colitis in mice. Front Immunol. 2017;8:1910-1910."}, {"Citation": "Silo\u015fi I, Boldeanu MV, Mogoant\u0103 S\u015e, et al. Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD). Rom J Morphol Embryol. 2014;55:1317-1324."}, {"Citation": "Vempati P, Popel AS, Mac Gabhann F. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. Cytokine Growth Factor Rev. 2014;25:1-19."}, {"Citation": "Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M. HIF-1\u03b1 induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol. 2007;42:1036-1044."}, {"Citation": "Li Q, Zhang X, Wang W, et al. CPT-11 activates NLRP3 inflammasome through JNK and NF-kappaB signalings. Toxicol Appl Pharmacol. 2015;289:133-141."}, {"Citation": "Goswami SK, Das DK. Oxygen sensing, cardiac ischemia, HIF-1\u03b1 and some emerging concepts. Curr Cardiol Rev. 2010;6(4):265-273."}, {"Citation": "Chang YC, Chan YC, Chang WM, et al. Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression. Cancer Lett. 2017;403:28-36."}, {"Citation": "Cunningham AC, Hasty KA, Enghild JJ, Mast AE. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Biochem J. 2002;367:451-458."}, {"Citation": "Belaaouaj AA, Li A, Wun TC, Welgus HG, Shapiro SD. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem. 2000;275:27123-27128."}, {"Citation": "Egorina EM, Sovershaev MA, Hansen J-B. The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrin. 2011;22:451-456."}, {"Citation": "Oe Y, Hayashi S, Fushima T, et al. Coagulation factor Xa and protease-activated receptor 2 as novel therapeutic targets for diabetic nephropathy. Arterioscler Thromb Vasc Biol. 2016;36:1525-1533."}, {"Citation": "Holz O, Tal-Singer R, Kanniess F, et al. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. J Clin Pharmacol. 2005;45:498-503."}, {"Citation": "Ucar F, Taslipinar MY, Alp BF, et al. The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model. Ren Fail. 2013;35:640-647."}, {"Citation": "Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Zimran A. Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci. 2001;46:2515-2520."}, {"Citation": "Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7:212-219."}, {"Citation": "McKenna DF, Borzabadi-Farahani A, Lynch E. The effect of subgingival ozone and/or hydrogen peroxide on the development of peri-implant mucositis: a double-blind randomized controlled trial. Int J Oral Maxillofac Implants. 2013;28:1483-1489."}, {"Citation": "Song M, Zeng Q, Xiang Y, et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep. 2018;17:2449-2455."}, {"Citation": "Zanker KS, Kroczek R. In vitro synergistic activity of 5-fluorouracil with low-dose ozone against a chemoresistant tumor cell line and fresh human tumor cells. Chemotherapy. 1990;36:147-154."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2019", "Month": "10", "Day": "29"}, {"Year": "2020", "Month": "7", "Day": "21"}, {"Year": "2020", "Month": "7", "Day": "24"}, {"Year": "2020", "Month": "8", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32776374", "10.1096/fj.201902717RR"]}}], "PubmedBookArticle": []}